#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	5218	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2696	474.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1767	1767	C	688	C,G,T,A	646,2,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	5218	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2696	474.4	0	HET	.	.	.	C207T,A	.	207	207	C	790	790	C	522	C,T,A	376,109,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	9486	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3963	590.2	0	.	n	.	0	T695C	SNP	695	695	T	1310	1310	C	763	C,A,T,G	718,3,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	9486	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3963	590.2	0	.	n	.	0	A1638G	SNP	1638	1638	A	2253	2253	G	646	G,A,T	614,5,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	9486	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3963	590.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2586	2586	C	669	C,T,A	628,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	9486	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3963	590.2	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3212	3212	T	654	T,C,G	624,2,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	9486	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3963	590.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2660	2660	A	639	A	606	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	500	folP	855	855	100.0	folP.l6.c17.ctg.1	1987	62.2	1	SNP	p	R229S	1	.	.	685	687	AGC	1265	1267	AGC	74;73;74	A,C;G;C	72,1;72;72	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1040	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3723	68.6	1	SNP	p	S91F	1	.	.	271	273	TTC	811	813	TTC	56;57;57	T;T;C	50;51;53	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1040	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3723	68.6	1	SNP	p	G95N	0	.	.	283	285	GGC	823	825	GGC	62;63;64	G;G;C	58;59;58	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1040	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3723	68.6	1	SNP	p	D95G	1	.	.	283	285	GGC	823	825	GGC	62;63;64	G;G;C	58;59;58	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	458	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1715	65.5	1	SNP	p	G45D	0	.	.	133	135	GGC	665	667	GGC	101;101;101	G;G;C	90;89;92	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	316	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1809	43.1	0	.	n	.	0	A197.	DEL	197	197	A	1094	1094	A	81	A	79	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1074	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3434	77.0	1	SNP	p	D86N	0	.	.	256	258	GAC	892	894	GAC	87;87;92	G;A;C	75;66;81	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1074	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3434	77.0	1	SNP	p	S87R	1	.	.	259	261	CGT	895	897	CGT	93;93;97	C,A;G;T	82,1;73;80	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1074	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3434	77.0	1	SNP	p	R87W	0	.	.	259	261	CGT	895	897	CGT	93;93;97	C,A;G;T	82,1;73;80	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1074	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3434	77.0	1	SNP	p	R87I	0	.	.	259	261	CGT	895	897	CGT	93;93;97	C,A;G;T	82,1;73;80	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1074	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3434	77.0	1	SNP	p	S88P	0	.	.	262	264	TCC	898	900	TCC	97;96;95	T;C,T;C	86;82,2;91	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	816	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3260	61.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1908	1910	GGC	56;57;57	G;G;C	50;54;53	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	908	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2322	94.1	1	SNP	p	A311V	0	.	.	931	933	GCC	1321	1323	GCC	114;115;115	G;C,A;C	108;108,1;109	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	908	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2322	94.1	1	SNP	p	I312M	1	.	.	934	936	ATG	1324	1326	ATG	116;115;113	A,G;T,G;G	109,1;108,1;107	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	908	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2322	94.1	1	SNP	p	T316P	0	.	.	946	948	ACC	1336	1338	ACC	115;115;115	A,G;C;C,G,A	107,2;109;107,1,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	908	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2322	94.1	1	SNP	p	V316T	1	.	.	946	948	ACC	1336	1338	ACC	115;115;115	A,G;C;C,G,A	107,2;109;107,1,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	908	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2322	94.1	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1837	1839	ACC	110;111;110	A;C;C	104;101;105	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	908	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2322	94.1	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1891	1893	GCG	101;100;100	G;C;G	95;89;88	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	908	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2322	94.1	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1891	1893	GCG	101;100;100	G;C;G	95;89;88	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	908	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2322	94.1	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2014	2016	GGT	64;64;64	G;G,T;T	62;59,3;63	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	908	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2322	94.1	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2023	2025	AGC	58;58;59	A,G;G,A;C,G	46,2;49,1;55,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	908	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2322	94.1	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2041	2043	CCG	50;48;45	C;C,A;G,C	44;39,1;40,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1506	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3709	100.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1941	1943	CCG	136;136;136	C,T,G;C,A;G,T,C,A	111,6,4;127,1;99,2,1,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	526	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2371	54.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	792	792	C	58	C	49	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	758	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	2222	84.4	0	.	p	.	0	R40Q	NONSYN	118	120	CGG	759	761	CAG	133;133;133	C;A,T;G,T	132;131,1;131,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	758	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	2222	84.4	1	SNP	p	G120K	1	.	.	358	360	AAG	999	1001	AAG	117;117;117	A,C;A;G,A	110,1;110;109,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	758	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	2222	84.4	1	SNP	p	A121N	1	.	.	361	363	AAC	1002	1004	AAC	118;118;119	A;A;C,A	110;113;111,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	758	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	2222	84.4	1	SNP	p	N121D	0	.	.	361	363	AAC	1002	1004	AAC	118;118;119	A;A;C,A	110;113;111,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2718	rpoB	4179	4179	99.98	rpoB.l6.c17.ctg.1	5420	124.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	440	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1652	66.6	1	SNP	p	V57M	1	.	.	169	171	ATG	864	866	ATG	137;134;135	A;T;G	123;127;128	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
